Pacific Biosciences of California, Inc. - PACB

SEC FilingsOur PACB Tweets

About Gravity Analytica

Recent News

  • 02.05.2026 - How SPRQ-Nx enables affordable long-read whole genome sequencing without added complexity
  • 02.02.2026 - PacBio Completes Sale of Short-Read Sequencing Assets
  • 01.29.2026 - Beyond the Bench: Advancing cancer transcriptomics with HiFi long-read RNA sequencing
  • 01.27.2026 - PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
  • 01.22.2026 - Publication spotlight: HiFi sequencing enables haplotype-specific chromatin mapping from single cells using DAF-seq
  • 01.15.2026 - 2025 Epigenetics SMRT Grant Awardees
  • 01.12.2026 - PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
  • 01.12.2026 - PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
  • 01.12.2026 - PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)
  • 01.09.2026 - A year in review: HiFi in the Headline

Recent Filings

  • 02.03.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 02.03.2026 - 8-K Current report
  • 02.02.2026 - EX-99.1 EX-99.1
  • 02.02.2026 - 8-K Current report
  • 01.12.2026 - EX-99.1 EX-99.1
  • 01.12.2026 - 8-K Current report